Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy Meeting Abstract


Authors: Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; Modi, S.; Troso-Sandoval, T.; Argolo, D.; Jack, K.; Ulaner, G.; Jochelson, M.; Baselga, J.; Norton, L.; Hudis, C. A.; Dang, C. T.
Abstract Title: Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
Meeting Title: 2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 77
Issue: 4 Suppl.
Meeting Dates: 2016 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2017-02-01
Language: English
ACCESSION: WOS:000397999002002
DOI: 10.1158/1538-7445.sabcs16-p4-21-34
PROVIDER: wos
Notes: Meeting Abstract: P4-21-34 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Gary Ulaner
    145 Ulaner
  2. Clifford Hudis
    904 Hudis
  3. Larry Norton
    734 Norton
  4. Chau Dang
    257 Dang
  5. Diana E Lake
    86 Lake
  6. Maura N Dickler
    262 Dickler
  7. Maxine Jochelson
    119 Jochelson
  8. Monica Nancy Fornier
    155 Fornier
  9. Ayca Gucalp
    106 Gucalp
  10. Tiffany A Traina
    233 Traina
  11. Shanu Modi
    239 Modi
  12. Komal Lachhman Jhaveri
    162 Jhaveri
  13. Shari Goldfarb
    142 Goldfarb
  14. Neil Mukund Iyengar
    133 Iyengar
  15. Jose T Baselga
    483 Baselga
  16. Jasmeet Chadha Singh
    21 Singh
  17. Lillian   Smyth
    42 Smyth
  18. Kellie Alexandra Jack
    4 Jack